Effects of Whole Body Vibration Training in Patients With Interstitial Lung Disease
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
- Scleroderma
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 75 years
- Gender
- Both males and females
Description
Patients: All participants with ILD will be recruited from a Cerrahpasa Medical Faculty Hospital between January 2017 and June 2018. All treatments will performed in the same hospital. Sample Size: "Power and Sample Size Program" was used to calculate sample size. Power analysis was done with Pass 1...
Patients: All participants with ILD will be recruited from a Cerrahpasa Medical Faculty Hospital between January 2017 and June 2018. All treatments will performed in the same hospital. Sample Size: "Power and Sample Size Program" was used to calculate sample size. Power analysis was done with Pass 11 Home program. In the power analysis program, ? = 0,05, ? = 0,15 1- ? = 0,84. When the number of samples of the groups was 30 and 30, 84% power was obtained. Using a two-sided two-sample t-test, the standard deviations from the 0,05 alpha value are 7.0 and 6.0. Procedure: A list of individuals diagnosed with interstitial lung disease who are following the outpatient clinic of the Department of Chest Diseases of the Istanbul University Cerrahpa?a Medical Faculty and who meet the inclusion criteria for the study will be created. The created patient list will be enumerated. Two groups will be formed from the numbered persons by the random number table method (n = 60). Groups will receive 30 participants in the treatment group, whose protocol numbers end in an even number, and 30 members in the control group, who finished with an odd number of protocol numbers. Up to 10% of the sample size will be selected as a substitute, taking into account the non-participation of the selected individuals in the study. Assessments at baseline and after training will be performed by pulmonary physiotherapist. All the participants will be treated in the Cerrahpa?a Medical Faculty hospital by a physiotherapist who is experienced in pulmonary rehabilitation.
Tracking Information
- NCT #
- NCT03560154
- Collaborators
- Not Provided
- Investigators
- Study Director: Zerrin Yi?it, Prof Istanbul University/Institute of Cardiology